Expert Opinion on Therapeutic Targets

New solid tumor targets for therapeutic monoclonal antibodies
pp. 585-588(4)
Author: Papkoff, Jackie

Targeting the PI3K and MAPK pathways to treat Kaposi's sarcoma-associated herpes virus infection and pathogenesis
pp. 589-599(11)
Authors: Lambert, Phelps J; Shahrier, Aniqa Z; Whitman, Audy G; Dyson, Ossie F; Reber, Adrian J; McCubrey, James A; Akula, Shaw M

IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases
pp. 601-612(12)
Authors: Sabat, Robert; Wallace, Elizabeth; Endesfelder, Stefanie; Wolk, Kerstin

The IL-6/sIL-6R complex as a novel target for therapeutic approaches
pp. 613-624(12)
Authors: Rose-John, Stefan; Waetzig, Georg H; Scheller, Jürgen; Grötzinger, Joachim; Seegert, Dirk

New therapeutic targets in atrophic age-related macular degeneration
pp. 625-639(15)
Author: Petrukhin, Konstantin

Multifaceted targeting in cancer: the recent cell death players meet the usual oncogene suspects
pp. 641-659(19)
Authors: Drosopoulos, Konstantinos; Pintzas, Alexander

Fatty acid receptors as new therapeutic targets for diabetes
pp. 661-671(11)
Authors: Rayasam, Geetha Vani; Tulasi, Vamshi Krishna; Davis, Joseph Alex; Bansal, Vinay S

Targeting signal transduction in pancreatic cancer treatment
pp. 673-694(22)
Authors: Yeh, Jen Jen; Der, Channing J

Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery
pp. 695-705(11)
Authors: Khan, Javed A; Forouhar, Farhad; Tao, Xiao; Tong, Liang

The potential for phospholipase D as a new therapeutic target
pp. 707-716(10)
Authors: Huang, Ping; Frohman, Michael A

Towards the discovery of novel T-type calcium channel blockers
pp. 717-722(6)
Authors: Lory, Philippe; Chemin, Jean